Literature DB >> 24065570

Breast cancer brain metastases responding to primary systemic therapy with T-DM1.

Rupert Bartsch1, Anna S Berghoff, Matthias Preusser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24065570     DOI： 10.1007/s11060-013-1257-5

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  2 in total

1.  Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases.

Authors:  Paul W Sperduto; Norbert Kased; David Roberge; Zhiyuan Xu; Ryan Shanley; Xianghua Luo; Penny K Sneed; Samuel T Chao; Robert J Weil; John Suh; Amit Bhatt; Ashley W Jensen; Paul D Brown; Helen A Shih; John Kirkpatrick; Laurie E Gaspar; John B Fiveash; Veronica Chiang; Jonathan P S Knisely; Christina Maria Sperduto; Nancy Lin; Minesh Mehta
Journal:  J Clin Oncol       Date:  2011-12-27       Impact factor: 44.544

2.  Trastuzumab emtansine for HER2-positive advanced breast cancer.

Authors:  Sunil Verma; David Miles; Luca Gianni; Ian E Krop; Manfred Welslau; José Baselga; Mark Pegram; Do-Youn Oh; Véronique Diéras; Ellie Guardino; Liang Fang; Michael W Lu; Steven Olsen; Kim Blackwell
Journal:  N Engl J Med       Date:  2012-10-01       Impact factor: 91.245
  2 in total
  26 in total

1.  Response of symptomatic brain metastases from HER-2 overexpressing breast cancer with T-DM1.

Authors:  C L Gorter de Vries; S C Linn; D Brandsma
Journal:  J Neurooncol       Date:  2016-01-05       Impact factor: 4.130

Review 2.  Systemic Therapy for HER2-Positive Central Nervous System Disease: Where We Are and Where Do We Go From Here?

Authors:  Eleonora Teplinsky; Francisco J Esteva
Journal:  Curr Oncol Rep       Date:  2015-10       Impact factor: 5.075

3.  ABC4 Consensus: Assessment by a German Group of Experts.

Authors:  Nadia Harbeck; Diana Lüftner; Norbert Marschner; Michael Untch; Doris Augustin; Susanne Briest; Johannes Ettl; Renate Haidinger; Lothar Müller; Volkmar Müller; Eugen Ruckhäberle; Rachel Wuerstlein; Christoph Thomssen
Journal:  Breast Care (Basel)       Date:  2018-02-15       Impact factor: 2.860

Review 4.  Unsanctifying the sanctuary: challenges and opportunities with brain metastases.

Authors:  Shannon Puhalla; William Elmquist; David Freyer; Lawrence Kleinberg; Chris Adkins; Paul Lockman; John McGregor; Leslie Muldoon; Gary Nesbit; David Peereboom; Quentin Smith; Sara Walker; Edward Neuwelt
Journal:  Neuro Oncol       Date:  2015-05       Impact factor: 12.300

Review 5.  Immunotherapy and targeted therapy in brain metastases: emerging options in precision medicine.

Authors:  Tyler Lazaro; Priscilla K Brastianos
Journal:  CNS Oncol       Date:  2017-04

6.  Activity of T-DM1 in HER-2 positive central nervous system breast cancer metastases.

Authors:  Sofia Torres; Pejman Maralani; Sunil Verma
Journal:  BMJ Case Rep       Date:  2014-08-14

Review 7.  Systemic therapy of brain metastases.

Authors:  Harry C Brastianos; Daniel P Cahill; Priscilla K Brastianos
Journal:  Curr Neurol Neurosci Rep       Date:  2015       Impact factor: 5.081

Review 8.  Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases.

Authors:  Neal Shah; Afroz S Mohammad; Pushkar Saralkar; Samuel A Sprowls; Schuyler D Vickers; Devin John; Rachel M Tallman; Brandon P Lucke-Wold; Katherine E Jarrell; Mark Pinti; Richard L Nolan; Paul R Lockman
Journal:  Pharmacol Res       Date:  2018-03-28       Impact factor: 7.658

9.  Brain metastases as site of first and isolated recurrence of breast cancer: the role of systemic therapy after local treatment.

Authors:  Anna Niwińska
Journal:  Clin Exp Metastasis       Date:  2016-05-25       Impact factor: 5.150

10.  Preclinical Efficacy of Ado-trastuzumab Emtansine in the Brain Microenvironment.

Authors:  Vasileios Askoxylakis; Gino B Ferraro; David P Kodack; Mark Badeaux; Ram C Shankaraiah; Giorgio Seano; Jonas Kloepper; Trupti Vardam; John D Martin; Kamila Naxerova; Divya Bezwada; Xiaolong Qi; Martin K Selig; Elena Brachtel; Dan G Duda; Peigen Huang; Dai Fukumura; Jeffrey A Engelman; Rakesh K Jain
Journal:  J Natl Cancer Inst       Date:  2015-11-07       Impact factor: 13.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.